Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Scanleaf ApS
APS
Dissolved
Advertising protection
CVR 39900351
Stubmarken 5, 3450
Allerød
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2018 · 7 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Scanleaf ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (2)
PE
Peter Emil Guldmann Sigetty
Management
Management
2025 – 2026
HH
Hasse Herlevsen
Chief Executive Officer
Chief Executive Officer
2018 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Former (2)
PP
Pete Patterson
Chairman
Chairman
2022 – 2026
MS
Mike Steen Hansen
Board of Directors
Board of Directors
2022 – 2026
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
rightQA.dk Consultancy ApS
Company
5–9.99%
5–9.99%
2022
168 aps
Company
50–66.65%
50–66.65%
2022
Ai-Chin Lin Brorsen
Individual
50–66.65%
50–66.65%
2019
Herlevsen Holding ApS
Company
20–24.99%
20–24.99%
2022
Redhare ApS
Company
20–24.99%
20–24.99%
2022
Valcon Medical A/S
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Scanleaf ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network